High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial
Yu Zhang(Guangdong Academy of Medical Sciences), Li Xuan(Commercial Aircraft Corporation of China (China)), Qing Zhang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Dan Xu(Nanfang Hospital), Qifa Liu(University of Science and Technology of China), Fen Huang(Nanfang Hospital), Zinan Feng(Nanfang Hospital), Danian Nie(Sun Yat-sen University), Xiong Zhang(Third People's Hospital of Chengdu), Xuejie Jiang(Nanfang Hospital), Hui Liu(Capital Medical University), Hong Qu(Panyu District Central Hospital), Guopan Yu(Nanfang Hospital), Xinlong Du(Shenzhen Second People's Hospital), Xiaojun Xu(Karolinska Institutet), Qianwei Liu(Northwest A&F University), Weihua Zhao(Guangxi Medical University), Xinquan Liang(Chenzhou First People's Hospital), Zhiping Fan(Nanchang University), Jing Du(Ministry of Education of the People's Republic of China), Jing Sun(Qiqihar University), Wenjie Xiong(Guangzhou First People's Hospital), Zhiqiang Sun, Hua Jin(University of California San Diego), Pengcheng Shi(Nanfang Hospital), Min Dai(Nanfang Hospital), Sijian Yu(Nanfang Hospital), Ziwen Guo(Zhongshan People's Hospital), Yirong Jiang(Dongguan People’s Hospital), Meiqing Wu(Guangxi Medical University), Ruoyang Shao(Nanfang Hospital)
Cited by 0
Related Papers
Genome sequence and genetic diversity of the common carp, Cyprinus carpio
|Nature Genetics|2014|677
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
|Cancer Letters|2021|456
Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America
|Cancer Letters|2021|449
Participation and yield of a population-based colorectal cancer screening programme in China
|Gut|2018|409
ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death
|New England Journal of Medicine|2013|403